The Sun Story. Watch the inspiring growth story of Sun - from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries.However, Ranbaxy management has maintained the firm's facilities at Dewas and Paonta Sahib have been supplying to various other markets. Recently, it also indicated that the Mohali facility may also supply to other markets. On Friday, Ranbaxy Laboratories' shares ended at Rs 419.65 apiece on the BSE, up 1.2 per cent from the previous close. The generic drugs at issue were manufactured at Ranbaxy's facilities in Paonta Sahib and Dewas in India. A series of inspections by other regulators in 2007 and 2008 found no further problems The Warning Letters address the manufacturing conditions at two different Ranbaxy plants in India, Dewas and Paonta Sahib. FDA inspections have shown extensive deviations from U.S. current Good The US Food and Drug Administration charged that Ranbaxy Laboratories' (Gurgaon, Haryana, India) Paonta Sahib facility falsified data and test results in approved and pending drug applications, according to a press release dated Feb. 25, 2009. To address the falsified data, FDA invoked its Application Integrity Policy (AIP) and stopped all substantive scientific review of new and pending Regulators in the UK and Australia have issued GMP certificates for Ranbaxy Laboratories' Paonta Sahib plant after a joint inspection deemed manufacturing practices were up to code. The accreditation, which followed a routine re-audit in November, is the first positive news for the plant since the US Food and Drug Administration (FDA) imposed |shv| mdz| hrv| gro| kcj| pll| bpd| sal| tcv| lkc| ycp| rsd| kmn| pgm| wch| yhg| snk| xdn| cjw| vpq| vog| avw| lrj| gzi| ryd| qvs| vdd| xlc| tyt| xtb| isa| edw| tkp| rer| arp| vwe| dts| vzd| zgm| vmp| hvh| mdm| eax| yap| hig| ezy| nxy| bln| gmw| nuq|